TFF Pharmaceuticals Inc (TFFP)
0.3761
-1.22
(-76.49%)
USD |
NASDAQ |
Nov 15, 16:00
0.3651
-0.01
(-2.92%)
After-Hours: 20:00
TFF Pharmaceuticals Enterprise Value: -3.084M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | -3.084M |
| November 14, 2024 | 1.158M |
| November 13, 2024 | 1.436M |
| November 12, 2024 | 1.886M |
| November 11, 2024 | 2.025M |
| November 08, 2024 | 1.436M |
| November 07, 2024 | 1.262M |
| November 06, 2024 | 1.228M |
| November 05, 2024 | 1.990M |
| November 04, 2024 | 2.198M |
| November 01, 2024 | 2.441M |
| October 31, 2024 | 4.278M |
| October 30, 2024 | 4.312M |
| October 29, 2024 | 2.891M |
| October 28, 2024 | 4.104M |
| October 25, 2024 | 3.827M |
| October 24, 2024 | 2.753M |
| October 23, 2024 | 3.739M |
| October 22, 2024 | 3.585M |
| October 21, 2024 | 3.585M |
| October 18, 2024 | 2.787M |
| October 17, 2024 | 2.753M |
| October 16, 2024 | 2.857M |
| October 15, 2024 | 3.099M |
| October 14, 2024 | 3.689M |
| Date | Value |
|---|---|
| October 11, 2024 | 3.481M |
| October 10, 2024 | 2.233M |
| October 09, 2024 | 2.129M |
| October 08, 2024 | 2.580M |
| October 07, 2024 | 1.956M |
| October 04, 2024 | 2.094M |
| October 03, 2024 | 2.094M |
| October 02, 2024 | 2.164M |
| October 01, 2024 | 1.852M |
| September 30, 2024 | 2.580M |
| September 27, 2024 | 2.545M |
| September 26, 2024 | 3.099M |
| September 25, 2024 | 2.372M |
| September 24, 2024 | 2.337M |
| September 23, 2024 | 2.580M |
| September 20, 2024 | 3.619M |
| September 19, 2024 | 3.619M |
| September 18, 2024 | 3.515M |
| September 17, 2024 | 3.793M |
| September 16, 2024 | 3.203M |
| September 13, 2024 | 3.273M |
| September 12, 2024 | 3.273M |
| September 11, 2024 | 3.134M |
| September 10, 2024 | 2.372M |
| September 09, 2024 | 2.372M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.084M
Minimum
Nov 15 2024
409.77M
Maximum
Jan 20 2021
100.97M
Average
70.52M
Median
Enterprise Value Benchmarks
| Eyenovia Inc | 19.61M |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 8.735M |
| iBio Inc | 6.468M |
| Theriva Biologics Inc | -13.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.479M |
| Revenue (Quarterly) | 0.6502M |
| Total Expenses (Quarterly) | 4.613M |
| EPS Diluted (Quarterly) | -1.22 |
| Profit Margin (Quarterly) | -688.9% |
| Earnings Yield | -1.99K% |
| Normalized Earnings Yield | -1945.54 |